Skip to main content

Moors & Cabot, Inc.

Position in LLY — ELI LILLY & Co

CIK 1607239 BOSTON, MA

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$27,394,983
+$6,010,331 QoQ
Shares Held
22,840
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#751
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Dec 31, 2021
CallValue
$552
CallShares
2
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. LLY ranks #2 (23.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 LLY
ELI LILLY & Co
This page
22,840 $27,394,983

All Filings in LLY

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,394,983 22,840
2026-03-31 $21,384,652 23,250
2025-12-31 $25,043,270 23,303
2025-09-30 $17,011,085 22,295
2025-06-30 $17,158,234 22,011
2025-03-31 $18,199,752 22,036
2024-12-31 $15,778,136 20,438
2024-09-30 $18,977,720 21,421
2024-06-30 $18,906,145 20,882
2024-03-31 $15,289,247 19,653
2023-12-31 $11,844,351 20,319
2023-09-30 $10,959,600 20,404
2023-06-30 $10,258,937 21,875
2023-03-31 $7,594,733 22,115
2022-12-31 $6,429,272 17,574
2022-09-30 $6,943,941 21,475
2022-06-30 $7,490,037 23,101
2022-03-31 $6,567,036 22,932
2021-12-31 $552 2
2021-12-31 $6,589,228 23,855
2021-09-30 $4,747,846 20,549
2021-06-30 $4,180,247 18,213
2021-03-31 $3,434,872 18,386
2020-12-31 $3,027,470 17,931
2020-09-30 $2,263,373 15,291
2020-06-30 $2,699,775 16,444
2020-03-31 $2,557,025 18,433
2020-03-31 $1,942 14